CAK-independent activation of CDK6 by a viral cyclin Journal Article


Authors: Kaldis, P.; Ojala, P. M.; Tong, L.; Makela, T. P.; Solomon, M. J.
Article Title: CAK-independent activation of CDK6 by a viral cyclin
Abstract: In normal cells, activation of cyclin-dependent kinases (cdks) requires binding to a cyclin and phosphorylation by the cdk-activating kinase (CAK). The Kaposi's sarcoma-associated herpesvirus encodes a protein with similarity to D-type cyclins. This KSHV-cyclin activates CDK6, alters its substrate specificity, and renders CDK6 insensitive to inhibition by the cdk inhibitor P16(INK4a). Here we investigate the regulation of the CDK6/KSHV-cyclin kinase with the use of purified proteins and a cell-based assay. We find that KSHV-cyclin can activate CDK6 independent of phosphorylation by CAK in vitro. In addition, CAK phosphorylation decreased the p16(INK4a) sensitivity of CDK6/KSHV-cyclin complexes. In cells, expression of CDK6 or to a lesser degree of a nonphosphorylatable CDK6(T177A) together with KSHV-cyclin induced apoptosis, indicating that CDK6 activation by KSHV-cyclin can proceed in the absence of phosphorylation by CAK in vivo. Coexpression of p16 partially protected cells from cell death. p16 and KSHV-cyclin can form a ternary complex with CDK6 that can be detected by binding assays as well as by conformational changes in CDK6. The Kaposi's sarcoma-associated herpesvirus has adopted a clever strategy to render cell cycle progression independent of mitogenic signals, cdk inhibition, or phosphorylation by CAK.
Keywords: retinoblastoma protein; transcription factor tfiih; dependent kinase inhibitor; kaposis-sarcoma; cell-cycle; sarcoma-associated herpesvirus; ring finger protein; catalytic subunit; potential mediator; b-type cyclins
Journal Title: Molecular Biology of the Cell
Volume: 12
Issue: 12
ISSN: 1059-1524
Publisher: The American Society for Cell Biology  
Date Published: 2001-12-01
Start Page: 3987
End Page: 3999
Language: English
ACCESSION: WOS:000172701100021
PROVIDER: wos
PUBMED: 11739795
DOI: 10.1091/mbc.12.12.3987
PMCID: PMC60770
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics